Status:
COMPLETED
Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma
Lead Sponsor:
Johns Hopkins University
Conditions:
Scleroderma
Gastroparesis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
An innovative method of needleless transcutaneous electroacupuncture (TEA) using a newly developed watch-size stimulator is proposed. Weak electrical current will be delivered via skin surface electro...
Eligibility Criteria
Inclusion
- No any systemic diseases;
- no scleroderma; no history of gastrointestinal surgery;
- no dyspeptic symptoms during the past 2 weeks;
- not taking any medications except contraceptives during the past 2 weeks;
- age 18 and older.
Exclusion
- History of any systemic diseases or surgeries;
- allergic to adhesives; pregnancy;
- unable to sign the consent form.
Key Trial Info
Start Date :
February 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2019
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03294616
Start Date
February 6 2017
End Date
November 20 2019
Last Update
November 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States, 21224